Literature DB >> 1700809

Corticonigral degeneration with neuronal achromasia. A clinicopathologic study of two cases.

C F Lippa1, T W Smith, N Fontneau.   

Abstract

We describe the clinical and neuropathological features of two patients having corticonigral degeneration with neuronal achromasia (CND). Both patients had cognitive decline and movement disorders. Magnetic resonance (MR) scans showed cortical atrophy, which in one case was most prominent in the parasylvian region, and ventricular enlargement in both cases. Neuropathological examination revealed swollen achromasic neurons within the cerebral cortex and marked neuronal loss in the substantia nigra. No Pick bodies, Lewy bodies, histologic changes of Alzheimer's disease, or spongiform change were present in either case. The diagnosis of CND should be considered in patients with complex movement disorders, with or without abnormalities in cognitive function.

Entities:  

Mesh:

Year:  1990        PMID: 1700809     DOI: 10.1016/0022-510x(90)90271-n

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.

Authors:  P S Mathuranath; J H Xuereb; T Bak; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

2.  Corticobasal Degeneration.

Authors:  Panida Piboolnurak; Cheryl H. Waters
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

3.  Neuropsychological and neuroimaging correlates in corticobasal degeneration.

Authors:  E Frasson; G Moretto; A Beltramello; N Smania; M Pampanin; C Stegagno; R Tanel; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1998-10

4.  Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy.

Authors:  M B Feany; H Ksiezak-Reding; W K Liu; I Vincent; S H Yen; D W Dickson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Widespread cytoskeletal pathology characterizes corticobasal degeneration.

Authors:  M B Feany; D W Dickson
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

6.  Corticobasal degeneration with neither argyrophilic inclusions nor tau abnormalities: a new subgroup?

Authors:  K Kawasaki; K Iwanaga; K Wakabayashi; M Yamada; H Nagai; J Idezuka; Y Homma; F Ikuta
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

7.  Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles.

Authors:  D S Horoupian; P L Chu
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Presenile dementia with progressive supranuclear palsy tangles and Pick bodies: an unusual degenerative disorder involving the cerebral cortex, cerebral nuclei, and brain stem nuclei.

Authors:  K Arima; S Murayama; S Oyanagi; T Akashi; T Inose
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations.

Authors:  K Wakabayashi; K Oyanagi; T Makifuchi; F Ikuta; A Homma; Y Homma; Y Horikawa; S Tokiguchi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Ubiquitin-positive achromatic neurons in corticobasal degeneration.

Authors:  G M Halliday; L Davies; D A McRitchie; H Cartwright; R Pamphlett; J G Morris
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.